Brian Cogley's most recent trade in Coeptis Therapeutics Holdings Inc was a trade of 12,500 Common Stock done . Disclosure was reported to the exchange on Feb. 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coeptis Therapeutics Holdings Inc | Brian Cogley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 12,500 | 22,500 | - | 0 | Common Stock | |
| Coeptis Therapeutics Holdings Inc | Brian Cogley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.56 per share. | 11 Feb 2026 | 10,000 | 22,500 | - | 10.6 | 105,600 | Common stock |
| Coeptis Therapeutics Holdings Inc | Brian Cogley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 10,000 | 22,500 | - | - | Non-Qualified Stock Options (right to buy) | |
| Coeptis Therapeutics Holdings Inc | Brian Cogley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 10 Jan 2024 | 5,000 | 30,000 | - | 0.7 | 3,350 | Common Stock |